huseyin istanbullu

Dr. huseyin istanbullu

Pharmaceutical Chemistry, Izmir Kâtip Çelebi University, İzmir, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
huseyin istanbulluhuseyin istanbullu
huseyin istanbullu
GBGülşah Bayraktar
Gülşah Bayraktar
HAHasan Akbaba
Hasan Akbaba
ICIbrahim Cavus
Ibrahim Cavus
GCGunes Coban
Gunes Coban
EEErcin Erciyas
Ercin Erciyas

23 December 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
huseyin istanbulluhuseyin istanbullu
huseyin istanbullu
GBGülşah Bayraktar
Gülşah Bayraktar
GKGulsah Karakaya
Gulsah Karakaya
HAHasan Akbaba
Hasan Akbaba
NPNami Ege Perk
Nami Ege Perk
VAVildan Alptuzun
Vildan Alptuzun

5 August 2024 in Food & Function
Verified
Journal Article
Closed access
PDF file
HKHalil Koyu
Halil Koyu
huseyin istanbulluhuseyin istanbullu
huseyin istanbullu
SOSinem Ezgi Turunc Ozoglu
Sinem Ezgi Turunc Ozoglu
TTTijen Kaya Temiz
Tijen Kaya Temiz
Essential oil and 70% ethanol extract of Cinnamomum cassia bark can be evaluated to be used in products against HDAC 1 related diseases.

31 August 2014 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
huseyin istanbulluhuseyin istanbullu
huseyin istanbullu
YEYalcin Erzurumlu
Yalcin Erzurumlu
PKPetek Ballar Kirmizibayrak
Petek Ballar Kirmizibayrak
EEErcin Erciyas
Ercin Erciyas
A series of new “hybrid compounds”, Mannich base derivatives of planar polycyclic/heterocyclic starting materials, was designed and synthesized. The structures of the compounds were confirmed by spectroscopic methods and elemental analysis. Cytotoxicity of compounds was investigated in three cancer cell lines (PC3, HeLa, and MCF7) and one non-tumoral cell line (293 HEK). We tested the DNA-intercalating capability of the molecules by ethidium bromide (EtBr) fluorescence displacement experiment. Compounds' alkylation potency was investigated via in vitro incubation test using 2-mercaptoethanol, a biomimetic nucleophile. The five of the compounds (7s, 9d, 10b, 11b, 12c) are reported for first time in the literature. Our results suggest that compound 9d has a biological activity close to the reference compound doxorubicin, an intercalating agent in clinical use.

9 October 2024 in European Journal of Medicinal Chemistry Reports
Verified
Journal Article
Open access
GBGülşah Bayraktar
Gülşah Bayraktar
Pascal MarchandPascal Marchand
Pascal Marchand
EBEUZEBIO GUIMARAES BARBOSA
EUZEBIO GUIMARAES BARBOSA
MSMarilia Cecilia da Silva
Marilia Cecilia da Silva
KWKaren Cacilda Weber
Karen Cacilda Weber
huseyin istanbulluhuseyin istanbullu
huseyin istanbullu

4 January 2023
Verified
Book Chapter
Open access
PDF file
huseyin istanbulluhuseyin istanbullu
huseyin istanbullu
GBGülşah Bayraktar
Gülşah Bayraktar
MSMerve Saylam
Merve Saylam
Five-membered heteroaromatic ring fused pyridine derivatives are of increasing interest in drug design and medicinal chemistry. The structural similarity of many drugs (especially antiviral and anticancer ones) with DNA bases such as adenine and guanine is a key factor to explain their effectiveness. Apart from these, it is also found in the structures of substances with antituberculosis, antibacterial, antifungal, anti-inflammatory, and antimalarial activities. Another advantage of this group of compounds is their positive contribution to solubility, polarity, lipophilicity, and hydrogen bonding capacity properties of the compounds they are incorporated into. In this chapter, various bioactivities of fused pyridine derivatives will be categorized and summarized.